Head-to-head Comparison of Leading Blood Tests for Alzheimer’s Disease Pathology

Previous
Previous

The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field

Next
Next

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease